Stock Taper
| DATE | TYPE | RATIO |
|---|---|---|
| 2011-05-06 | Forward | 5:4 |
| 2003-12-03 | Forward | 4:3 |
| 2003-08-15 | Forward | 4:3 |
| 2002-04-12 | Forward | 5:4 |
| 2001-08-28 | Forward | 5:4 |
| 1991-07-16 | Forward | 3:2 |
Merit Medical Systems, Inc. designs, manufactures, and markets single-use interventional, diagnostic, and therapeutic medical products across cardiology, radiology, oncology, critical care, and endoscopy segments worldwide.

A newly FDA-approved stent graft with strong clinical data that prevents access site failure, ensuring long-term vessel patency for hemodialysis patients and potentially establishing a new standard of care.
| Icon | PRODUCT | Q3-2025 | Q4-2025 | Q1-2026 | Q2-2026 |
|---|---|---|---|---|---|
![]() | Cardiovascular | $366.43M | $373.88M ▲ | — | — |
![]() | Therapeutic | — | — | $126.4M | $137.88M ▲ |
![]() | Endoscopy | $17.73M | $20.06M ▲ | — | — |
![]() | Product and Service Other | — | — | — | $1.24M |
| Map | REGION | Q3-2025 | Q4-2025 | Q1-2026 | Q2-2026 |
|---|---|---|---|---|---|
![]() | UNITED STATES | — | — | $226.52M | $252.05M ▲ |
![]() | NonUS | $153.56M | $155.71M ▲ | $155.36M ▼ | $166.79M ▲ |
Overall rating: B+
| PEER | PRICE | |
|---|---|---|
GKOS | $179.87 | COMPARE |
KRYS | $351.46 | COMPARE |
BRKR | $57.08 | COMPARE |
TGTX | $53.93 | COMPARE |
ALKS | $47.41 | COMPARE |
TFX | $139.67 | COMPARE |
BLCO | $17.15 | COMPARE |
PTCT | $70.09 | COMPARE |